YELESWARAM KRISHNASWAMY (Chief Development Officer) sold 3.4% of their position (10.12K shares) of RAPPORT THERAPEUTICS, INC. on the open market
Open‑market sale worth $303.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/26/2026ACC: 0001193125-26-126410
Officer· Chief Development Officer
Since Feb 2026
-10.12K
Net shares
Net seller
$303.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.12K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.12K
Price / share
$29.99
Trade value
$303.35K
% of position
3.4%
3/25/2026
296.99K→286.88K
Total
Net shares
−10.12K
Net value
-$303.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/25/2026 | S · Sale | −10.12K | $29.99 | $303.35K | 3.4% | 296.99K | 286.88K |
| Total | −10.12K | -$303.35K | ||||||
Derivative Transactions0
No derivative transactions reported